TEL AVIV, Israel, Aug. 8, 2018 /PRNewswire/ -- Aidoc, a leading provider of AI solutions for radiologists announced today that it was granted Food and Drug Administration (FDA) clearance for the first product of its expanding suite of AI-based workflow optimization solutions. The clearance is for Aidoc's brain solution that works with radiologists to flag acute intracranial hemorrhage (ICH) cases in head CTs and is the world's first deep learning solution to assist radiologists in workflow triage.
With over 75% of all patient care involving radiology, the amount of imaging is skyrocketing while the number of radiologists is struggling to catch up. Radiologists are being pressured to produce quality results at a faster pace with increasing amounts of data - but with tools that are not up to the task. Aidoc solves this problem by providing radiologists with the most advanced solutions to increase efficiency and expedite patient care within their existing work environment.
Aidoc's solution analyzes medical images directly after the patient is scanned and notifies the radiologist of cases with suspected findings to assist with prioritization of time-sensitive, and potentially life-threatening cases. The FDA ruling is an indication of the company's impact on the healthcare AI industry and expanding clinical value.
"In a recent clinical study we ran, Aidoc's brain package demonstrated its potential to substantially reduce report turnaround time and increase the radiologist's confidence," said Dr. Barry D. Pressman, MD, Chairman of Imaging at Cedars-Sinai Medical Center and former president of ACR (American College of Radiology). "Seeing the software in action emphasized the key aspects an AI solution needs to possess to have an impact on the radiologist day to day - seamless integration into the workflow and broad applicability. With the evidence I've seen - in the not so distant future, it will almost be unthinkable to practice radiology without the assistance of solutions like Aidoc."
Already commercialized outside the US since December 2017, Aidoc is in the process of FDA clearance for the remainder of its solutions which will assist in the detection of a broad set of acute pathologies across the body. In under a year, Aidoc's solutions have already been deployed in over 50 medical centers worldwide, where they are used on a daily basis, analyzing over 1 million exams a year.
"We decided to focus our solution on acute pathologies where quality of care and time are of the essence," said Aidoc's CEO Elad Walach. "Radiologists are challenged with responding to large numbers of acute cases in a timely fashion. The key, we believe, is to be comprehensive. If you really want to impact the daily practice you have to cover a significant portion of the radiologist's workflow. Our solution can sift through the whole worklist in the background and highlight cases that require immediate attention, improving radiologist's response time."
Aidoc develops artificial intelligence solutions that support and enhance the impact of radiologist diagnostic power - helping them expedite patient treatment and improve quality of care. The company's solutions reduce turnaround time and increase quality and efficiency by flagging acute anomalies in real time. Radiologists benefit from state-of-the art deep learning technology that runs "behind the scenes" freeing them to focus on the diagnosis itself. Aidoc's healthcare-grade deep learning algorithms benefit from large quantities of data, making their solutions the most comprehensive in the field, and enabling them to provide diagnostic aid to the broadest set of pathologies.
Aidoc's founding team are alumni of elite technology units in the Israel Ministry of Defense. CEO and co-founder Elad Walach has led AI research at the Israeli Airforce and is a Forbes 30-under-30 healthcare innovator. With a team of leading technology experts and clinical thought-leaders, Aidoc technology helps millions get quicker and more efficient patient care. Aidoc is based in Tel-Aviv, Israel.
For further information: